Literature DB >> 14699450

Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp.

John T Brooks1, David Bergmire-Sweat, Malinda Kennedy, Kate Hendricks, Marianne Garcia, Lisa Marengo, Joy Wells, Michelle Ying, William Bibb, Patricia M Griffin, Robert M Hoekstra, Cindy R Friedman.   

Abstract

Few US clinical laboratories screen stool specimens for Shiga toxin-producing Escherichia coli (STEC) other than E. coli O157. An outbreak of STEC O111:H8 infections indistinguishable from E. coli O157:H7 at a youth camp highlights the need to improve non-O157 STEC surveillance. Interviews of 521 (80%) of 650 attendees revealed 55 (11%) were ill; 2 developed hemolytic-uremic syndrome. Illness was associated with consuming salad during the camp's first lunch meal (hazard ratio [HR], 4.68; P<.01), consuming ice provided in barrels on the camp's final day (HR, 3.41; P<.01), eating cob corn (HR, 3.22; P<.01), and eating a dinner roll (HR, 2.82; P<.01). Cultures of 2 of 11 stools yielded E. coli O111:H8. Results of serologic testing and additional stool cultures demonstrated no evidence of infection with other bacterial pathogens, including E. coli O157, and supported infection with E. coli O111. Clinical laboratories should routinely screen suspect specimens for non-O157 STEC and should serotype and report Shiga-positive isolates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14699450     DOI: 10.1086/380634

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Prevalence and virulence factors of Escherichia coli serogroups O26, O103, O111, and O145 shed by cattle in Scotland.

Authors:  M C Pearce; J Evans; I J McKendrick; A W Smith; H I Knight; D J Mellor; M E J Woolhouse; G J Gunn; J C Low
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 2.  E. coli O157:H7 and other toxigenic strains: the curse of global food distribution.

Authors:  Mary F Bavaro
Journal:  Curr Gastroenterol Rep       Date:  2012-08

3.  Association of nucleotide polymorphisms within the O-antigen gene cluster of Escherichia coli O26, O45, O103, O111, O121, and O145 with serogroups and genetic subtypes.

Authors:  Keri N Norman; Nancy A Strockbine; James L Bono
Journal:  Appl Environ Microbiol       Date:  2012-07-13       Impact factor: 4.792

4.  Simultaneous Presence of Insertion Sequence Excision Enhancer and Insertion Sequence IS629 Correlates with Increased Diversity and Virulence in Shiga Toxin-Producing Escherichia coli.

Authors:  M Toro; L V Rump; G Cao; J Meng; E W Brown; N Gonzalez-Escalona
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

5.  Pathoadaptive mutation that mediates adherence of shiga toxin-producing Escherichia coli O111.

Authors:  Alfredo G Torres; Roberto C Vazquez-Juarez; Christopher B Tutt; J Gerardo Garcia-Gallegos
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.

Authors:  Maurílio F Santos; Roger R C New; Gabrielle R Andrade; Christiane Y Ozaki; Osvaldo A Sant'Anna; Lucia Mendonça-Previato; Luis R Trabulsi; Marta O Domingos
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

7.  Laboratory practices and incidence of non-O157 shiga toxin-producing Escherichia coli infections.

Authors:  Kathleen A Stigi; J Kathryn Macdonald; Anthony A Tellez-Marfin; Kathryn H Lofy
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

8.  Genomic diversity of pathogenic Escherichia coli of the EHEC 2 clonal complex.

Authors:  Galeb S Abu-Ali; David W Lacher; Lukas M Wick; Weihong Qi; Thomas S Whittam
Journal:  BMC Genomics       Date:  2009-07-03       Impact factor: 3.969

9.  Shiga toxin-producing Escherichia coli, New Mexico, USA, 2004-2007.

Authors:  Sarah Lathrop; Karen Edge; Joseph Bareta
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

10.  A universal polysaccharide conjugated vaccine against O111 E. coli.

Authors:  Gabrielle R Andrade; Roger R C New; Osvaldo A Sant'Anna; Neil A Williams; Rosely C B Alves; Daniel C Pimenta; Hugo Vigerelli; Bruna S Melo; Letícia B Rocha; Roxane M F Piazza; Lucia Mendonça-Previato; Marta O Domingos
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.